MDedge News

Even With Insurance, Cancer OOP Costs Can Be Punishing Commercial health insurance does not necessarily protect cancer patients from potentially devastating out-of-pocket costs.
MDedge News, December 05, 2023
Addressing Chemo-Related Amenorrhea in Early BRCA Persistent chemotherapy-related amenorrhea (CRA) after treatment for breast cancer was common and associated with worse long-term quality of life among premenopausal women.
MDedge News, December 05, 2023
ASH 2023 ASH 2023: Equity, Sickle Cell, and Real-Life Outcomes Health equity, sickle cell disease, and the thoughtful use of artificial intelligence and social media are among the key themes to be presented at the annual meeting of the American Society of Hematology.
MDedge News, December 04, 2023
No Adverse Effects From Steroids in Pregnant Women With EoE 'Our recommendations about the use of steroids among this population are based on the safety data extrapolated mainly from pregnant women with asthma.'
MDedge News, December 01, 2023
Exercise Improves Physical, Cognitive Health in Down Synd 'The findings are significant and offer a crucial challenge to the [Down syndrome] and wider societies.'
MDedge News, December 01, 2023
ACG 2023 Tool Identifies Alcohol Relapse Risk After Liver Transplant A novel prognostic tool based on social determinants effectively predicted increased risk of alcohol use relapse in adults who underwent liver transplants for alcoholic liver disease.
MDedge News, December 01, 2023
Meta-Analysis: Suicide Risk Not Increased With Isotretinoin In fact, those treated with the drug for severe acne may have a lower risk for suicide attempts 2-4 years after treatment, according to the study authors.
MDedge News, December 01, 2023
Time to Stop Routine Maintenance Therapy in Myeloma? Physicians may need to rethink maintenance with lenalidomide (Revlimid and generics) for multiple myeloma.
MDedge News, November 30, 2023
Pancreatic Cystic Neoplasms Rarely Turn Cancerous Individuals with intraductal papillary mucinous neoplasms that lack 'worrisome or high-risk features' have no greater risk of pancreatic cancer than individuals without IPMNs.
MDedge News, November 30, 2023
Dietary Supplements May Play a Role in Managing Vitiligo Dietary supplements have a role in the integrative treatment of vitiligo, largely through antioxidant pathways and as an adjuvant to phototherapy.
MDedge News, November 30, 2023
ACG 2023 Two Choices for Resection Defect Repair Show Similar Success Two novel devices are similarly effective for tissue approximation of large endoscopic resection defects, but each has advantages.
MDedge News, November 30, 2023
Hemorrhage-Control Device Holds Up in Real-World Review An intrauterine vacuum-induced hemorrhage-control device provided prompt and effective management of bleeding in cases of obstetric hemorrhage.
MDedge News, November 30, 2023
Pilonidal Disease: Study Finds Laser Hair Removal Beneficial The study compared laser epilation plus standard of care with standard care alone for patients aged 11-20 years with pilonidal disease.
MDedge News, November 30, 2023
Avoid Added Stress When Treating Headache in LGBTQIA+ Pts Headache and headache associated with mood disorders are common among individuals from the LGBTQIA+ community, but preconceptions should be abandoned.
MDedge News, November 30, 2023
AHA 2023 New PCSK9 Inhibitor Allows 3-Month Treatment Intervals "It's a new antibody that has a long half-life so each treatment can be prolonged."
MDedge News, November 29, 2023
All-Oral Regimen Succeeds for Rifampin-Resistant TB A combination oral-only therapy of bedaquiline, pretomanid, and linezolid was significantly more effective than standard care in preventing unfavorable outcomes in patients with treatment-resistant tuberculosis.
MDedge News, November 29, 2023
Drugs to Prevent vs Those to Treat Migraine Might Not Share Targets 'I think this explains some of the frustration at trigger modulation. I think we are often trying to modulate a process that has already got started,' said Dr Peter Goadsby of King's College London.
MDedge News, November 29, 2023
ACG 2023 Low-Dose Aspirin: No Flares in Pregnant Patients With IBD Low-dose aspirin is recommended for pregnant women who are at risk of hypertensive disorders, such as eclampsia, preeclampsia, and gestational diabetes.
MDedge News, November 29, 2023
Tapinarof Effective for AD in Patients as Young as 2 years Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
MDedge News, November 28, 2023
Nail Psoriasis in Black Patients Often Overlooked Underrepresentation of Black patients with psoriasis in trials and textbooks might partially explain why clinicians are slow to recognize nail involvement, even after psoriasis has been diagnosed.
MDedge News, November 28, 2023
HS: Positive Results Reported With Anti-IL17A/F Therapies One of the trials evaluated a nanobody inhibitor, sonelokimab, a molecule with a substantially smaller size than traditional monoclonal antibodies.
MDedge News, November 28, 2023
EADV 2023 At 52 Weeks, Hair Growth Still Climbing on Deuruxolitinib With response curves still climbing at follow-up to date, the results are 'truly, truly remarkable.'
MDedge News, November 28, 2023
ACR 2023 Conditional Recommendations Rule in New SARD ILD Guidelines In spring 2024, the ACR is expected to release guidelines to help inform the screening, monitoring, and treatment of interstitial lung disease (ILD) in people with SARDs.
MDedge News, November 28, 2023
Telitacicept Shows Efficacy, Safety in MTX-Resistant RA Telitacicept is a recombinant fusion protein that aims to target and neutralize B lymphocyte stimulator and a proliferation-inducing ligand (APRIL), both of which are linked to autoimmunity.
MDedge News, November 28, 2023
ACR 2023 Abatacept Slows Progression to RA, Phase 2b Trial Finds The study was conducted at 28 sites in the United Kingdom and three in the Netherlands.
MDedge News, November 28, 2023
Quitting Tobacco Can Improve Lung Health in COPD Reducing exposure to tobacco smoke may reduce the burden of chronic obstructive pulmonary disease, and public health measures are needed.
MDedge News, November 28, 2023
ACR 2023 Benralizumab Proves Noninferior to Mepolizumab for EGPA Treatment with benralizumab (Fasenra) achieved remission at 36 and 48 weeks at rates similar to those of mepolizumab (Nucala) in a head-to-head phase 3 trial of the two drugs.
MDedge News, November 27, 2023
Studies Support Early Use of ULT, Warn of PAD A new analysis suggests that it may not be necessary to delay urate-lowering therapy in gout flares, and a study warns of the potential heightened risk for peripheral arterial disease in gout.
MDedge News, November 13, 2023
Rheumatology Trials Seem Vulnerable to Unblinding: Report Until more is known about the potential for unblinding, clinicians need to keep in mind that patients and physicians could often guess accurately who was getting placebo or active drug.
MDedge News, August 29, 2023
Poor Sleep Tied to Increased Risk of Suicidal Thoughts Suicide remains the second leading cause of death in young adults, but factors that may predict increased suicide risk have not been characterized.
MDedge News, August 23, 2023
Piroxicam Boosts Levonorgestrel for Emergency Contraception Adding oral piroxicam to oral levonorgestrel significantly improved the efficacy of emergency contraception on the basis of data from 860 women.
MDedge News, August 21, 2023
Primary Care Vision Testing Rates in Children Low Vision testing rates by primary care physicians in children were low and differed by insurance status, an anlysis of pooled data found.
MDedge News, August 17, 2023
Gout: Suboptimal Management a Continuing Problem Although urate-lowering drugs form the cornerstone of gout therapy, there are only three oral medications currently available in the United States, and all have significant limitations.
MDedge News, August 09, 2023
Social Needs Case Management Cuts Acute Care Usage Hospitalizations fell by 11% in patients assigned to integrated social needs case management. The reduction in acute care use was likely because of the 3% increase in primary care visits.
MDedge News, August 08, 2023
Innovations in Pediatric Chronic Pain Management The most important development in chronic pediatric pain has been the growth of rehab centers that include the medical team, practitioners from psychology, and occupational and physical therapy.
MDedge News, August 01, 2023

No Results